Trump: Look at the Slow-Moving FDA

January 31, 2025 by rstreet.org

Trump: Look at the Slow-Moving FDA

The FDA's slow approval of Zyn nicotine pouches raises concerns about its bureaucratic process. The delay contrasts with the product's potential to reduce harm from smoking. The FDA took nearly five years to approve Zyn, despite its lower health risks compared to cigarettes. While the FDA eventually approved Zyn, questions remain about its sluggish process. Streamlining approvals for similar products could improve public health outcomes. The FDA's delay in approving safer alternatives to cigarettes highlights the need for regulatory reform.


Categories:


TOP NEWS by REGION

July 27, 2023, 1:04 p.m. by news-medical.net

Tobacco dependence more likely in cigarette smokers, study reveals

Regions: Global

July 28, 2023, 11:16 a.m. by linkedin.com

Forecasting Nicotine Pouches Market till 2023-2030

Regions: Global

July 30, 2023, 11:33 p.m. by regulatorwatch.com

Vital Warning | WHO Is Coming for Your Vapes at COP10 | RegWatch

Regions: Global

July 30, 2023, 8:51 p.m. by colinmendelsohn.com.au

Stop Smoking Start Vaping e-book now free

Regions: Global

Aug. 8, 2023, 9:45 a.m. by insidesources.com

WHO Has Changed Course on Harm Reduction Before; It Must Do So Again

Regions: Global